All posts by imreal

VGXI Enables Rapid GMP DNA Manufacturing Timeline for Geneos Therapeutics Personalized Cancer Immunotherapy


VGXI - Geneos Logos

This achievement represents the first personalized neoantigen vaccine product manufactured for Geneos’ clinical studies, and I am confident [VGXI] will continue to deliver unparalleled product quality and rapid turnaround for subsequent patients as enrollment of the trial proceeds.

Leading plasmid DNA contract manufacturer VGXI, Inc. announced it has completed accelerated cGMP manufacturing of the first clinical batch of a personalized neoantigen vaccine for its client Geneos Therapeutics, Inc. Geneos is focused on developing DNA-based, neoantigen-targeting personalized cancer immunotherapies. Starting with receipt of seed plasmid DNA from Geneos, the VGXI team achieved a record-setting timeline of 5 days from host cell transformation to filled drug product manufacturing, and less than 2 weeks from transformation to release and shipment of the patient’s first dose. Overall, these timelines are a fraction of the 6 to 8 month turnaround time for GMP plasmid DNA that is standard in the industry, and they have been accomplished while maintaining the exceptional product quality for which VGXI is well known.

“Decades of experience and optimization of VGXI’s established, proprietary methods for DNA plasmid purification have allowed us to support the unique requirements of our client’s project.” Stated VGXI CEO Young Park. “This achievement represents the first personalized neoantigen vaccine product manufactured for Geneos’ clinical studies, and I am confident we will continue to deliver unparalleled product quality and rapid turnaround for subsequent patients as enrollment of the trial proceeds.”

VGXI’s efforts represent a critical element of Geneos’ integrated GT-EPIC™ platform. Geneos has established a broad collaboration created specifically to achieve the rapid biopsy-to-treatment turnaround times needed for personalized cancer therapies. The full GT-EPIC™ platform includes patient tumor exome/transcriptome sequencing and identification of the relevant neoantigen targets followed by neoantigen vaccine design, synthesis of the seed plasmid DNA, vaccine manufacture, and final delivery of the personalized neoantigen vaccine – with all platform elements executed within an overall timeline of 6 – 8 weeks. The patient specific GMP product lots manufactured under the VGXI supply agreement will support Geneos’ previously announced GT-30 clinical trial focused on the treatment of patients with advanced hepatocellular cancer.

Dr. Niranjan Y. Sardesai, Geneos’ Co-Founder, President & CEO said, “Achievement of rapid biopsy-to-treatment manufacturing turnaround times is an important differentiating milestone for the GT-EPIC™ platform in enabling these personalized treatments to be available faster for advanced cancer patients. We are pleased with our plasmid manufacturing partnership with VGXI in support of our GT-30 clinical trial. With their proven GMP manufacturing expertise, VGXI rose to the challenge and has enabled us to achieve our rapid manufacturing goals.”

ABOUT VGXI, INC.

VGXI, Inc. has nearly 20 years of experience and is a leading provider of plasmid DNA manufacturing and development services. The company has a reputation of success in manufacturing DNA products under cGMP conditions for clinical trials in the US, EU, Asia, Canada, and Australia, and its cGMP and non-GMP products have passed rigorous reviews by several international regulatory agencies. VGXI’s ability to work with unique requirements and create custom manufacturing solutions is based on its patented manufacturing process, flexible cGMP production facility, and experienced development team. VGXI, Inc. is a wholly-owned subsidiary CDMO of GeneOne Life Science, Inc. To learn more, visit https://www.vgxii.com.

ABOUT GENEONE LIFE SCIENCE

GeneOne Life Science Inc. (“GeneOne” KOSPI: 011000) is an international DNA vaccine and product developer, and leading contract manufacturer of DNA plasmid-based agents for pre-clinical and clinical trials for global companies and institutions. It researches and develops DNA vaccines and products to prevent and treat incurable diseases in South Korea and internationally. The company is headquartered in Seoul, South Korea. VGXI, Inc., GeneOne’s wholly-owned subsidiary located in Texas, is a leading cGMP DNA plasmid manufacturing facility. For more information, visit http://www.genels.com.

ABOUT GENEOS THERAPEUTICS

At Geneos Therapeutics, we believe that personalized therapies are the future of cancer treatment. Our passion is to develop personalized therapies to unleash the most powerful force against cancer – your body’s own immune system. Our approach using our GT-EPIC™ platform is to target unique neoantigens (abnormal mutations produced by cancer cells) from individual patient tumors to develop novel treatments for cancer. We have an experienced management team with a track record of success in building immunotherapy-based companies. Geneos was created as a spinout of Inovio Pharmaceuticals, Inc. (NASDAQ: INO). For more information, visit http://www.geneostx.com

CAUTIONARY FACTORS THAT MAY AFFECT FUTURE RESULTS

Materials in this press release contain information that includes or is based upon forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Forward-looking statements relate to expectations or forecasts of future events. These statements can be identified by the fact that they do not relate strictly to historical or current facts. They include words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other words and terms of similar meaning in connection with a discussion of potential future events, circumstances or future operating or financial performance. In particular, these include statements relating to future actions, prospective products or product approvals, future performance or results of current and anticipated products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, and financial results. Any or all of our forward-looking statements here or in other publications may turn out to be incorrect. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining our actual future results. Consequently, no forward-looking statement can be guaranteed, and forward-looking statements may be adversely affected by factors, including general market conditions, competitive product development, product availability, current and future branded and generic competition, federal and state regulations and legislation, manufacturing issues, timing of the elimination of trade buying, patent positions, litigations and investigations. Our actual results may vary materially, and there are no guarantees about the performance or valuation of GeneOne stock. It is also important to read the disclosure notice contained in many of the individual GeneOne documents available on the website, as many contain important information on such cautionary factors as of the date of the individual document. We undertake no obligation to correct or update any forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our reports.

Share article on social media or email:

Arteris® IP FlexNoC® Interconnect and AI Package Licensed by Blue Ocean Smart System for AI Chips


News Image

Arteris IP, the world’s leading supplier of innovative, silicon-proven network-on-chip (NoC) interconnect intellectual property, today announced that Blue Ocean Smart System has licensed Arteris FlexNoC Interconnect IP and the accompanying AI Package for use in next generation systems-on-chip (SoC) that hardware accelerate artificial intelligence (AI) neural network inference and training.

“From prior experience, I knew that Arteris interconnect IP was the best solution to construct complex high frequency and high bandwidth on-chip interconnects that were backend friendly for easier timing closure. The addition of the AI Package allows us to finely tune our chip architecture using multicast write semantics which greatly reduce off-chip memory accesses while using little die area and consuming much less power,” said John Rowland, President of Blue Ocean Smart System. “Our use of Arteris FlexNoC and the AI Package has been key to turning our architectural dreams into system-on-chip reality.”

John Rowland added, “The Arteris IP team and technology have been crucial to optimizing our on-chip dataflow for our unique AI chip architecture. Arteris IP has been a great partner providing best-in-class technology and world-class technical support.”

“Blue Ocean’s choice of our NoC interconnect IP for their novel AI accelerator chips is a resounding vote of confidence in our technology’s ability to tackle the high speed and on-chip bandwidth demands of artificial intelligence and machine learning SoCs,” said K. Charles Janac, President and CEO of Arteris IP. “Arteris IP is the only IP company 100% focused on creating unique on-chip interconnect technologies that accelerate the development and performance of complex AI SoC architectures.”

About Blue Ocean Smart System

Blue Ocean Smart System is a China-based leading artificial intelligence (AI) SoC start-up semiconductor company, founded by Dr. Leo Li in 2019. Dr. Li is China’s preeminent figure in the international semiconductor industry. The company delivers innovative chip architecture that is recognized by top international semiconductor companies with top-level global IC R&D teams in the United States and Asia-Pacific region. Its unique scalable chiplet architecture enables ASIC platforms from Edge to Cloud. The company has 3 R&D centers in Nanjing, Shanghai and Taiwan. Blue Ocean Smart System completed its Series A funding led by IDG capital and Arm China in 2019. http://www.blueoceansmart.com

About Arteris IP

Arteris IP provides network-on-chip (NoC) interconnect IP to accelerate system-on-chip (SoC) semiconductor assembly for a wide range of applications from AI to automobiles, mobile phones, IoT, cameras, SSD controllers, and servers for customers such as Baidu, Mobileye, Samsung, Huawei / HiSilicon, Toshiba and NXP. Arteris IP products include the Ncore® cache coherent and FlexNoC® non-coherent interconnect IP, the CodaCache® standalone last level cache, and optional Resilience Package (ISO 26262 functional safety), FlexNoC AI Package, and PIANO® automated timing closure capabilities. Customer results obtained by using Arteris IP products include lower power, higher performance, more efficient design reuse and faster SoC development, leading to lower development and production costs. For more information, visit http://www.arteris.com or find us on LinkedIn at https://www.linkedin.com/company/arteris.

Arteris, FlexNoC, Ncore, CodaCache, PIANO, Arteris IP and the Arteris IP logo are registered trademarks of Arteris, Inc. All other product or service names are the property of their respective owners.

###

Share article on social media or email:

Leading Implant Specialist in Austin, TX, Dr. Dan Holtzclaw Hosts…


Dr. Dan Holtzclaw and Noris Medical Dental Implant Solutions host a webinar on immediate full mouth dental implants on May 21, 2020. Having placed over 25,000 dental implants, Dr. Holtzclaw and his…

(PRWeb May 19, 2020)

Read the full story at https://www.prweb.com/releases/leading_implant_specialist_in_austin_tx_dr_dan_holtzclaw_hosts_webinar_on_immediate_full_mouth_dental_implants/prweb17131472.htm

Periodontist in Eden Prairie, MN Offers Minimally Invasive Dental Implant Surgery Using PIEZOSURGERY® Technology


Dr. Andres Sanchez, Periodontist in Eden Prairie, MN

Dr. Andres Sanchez, Periodontist in Eden Prairie, MN, Offers Less Invasive Dental Implant Surgery

We utilize PIEZOSURGERY for a wide range of services when we need to be extra careful in the mouth. This allows us to carefully remove bone, diseased teeth, or access the sinus cavity without putting the patient’s health at risk.

Experienced periodontist in Eden Prairie, MN, Dr. Andres Sanchez, offers a virtually pain-free solution to help patients get dental implants and bone grafting through PIEZOSURGERY® technology. PIEZOSURGERY uses ultrasonic vibrations to gently cut bone in the mouth without harming surrounding tissues. This is often used to prepare a patient for dental implants, especially when the implants need to be placed in a sensitive area of the mouth.

“We utilize PIEZOSURGERY for a wide range of services when we need to be extra careful in the mouth. This allows us to carefully remove bone, diseased teeth, or access the sinus cavity without putting the patient’s health at risk,” says Dr. Sanchez.

PIEZOSURGERY is so unique because it cuts using ultrasonic vibrations instead of drills and burs. This difference means that Dr. Sanchez can offer more precise care without damaging soft tissue. It is often used during dental implant treatments, including assisting in tooth extraction or a sinus lift when implants need to be placed in the upper molar region of the mouth. When used to prepare for dental implants, it often improves the healing time, both before and after surgery. PIEZOSURGERY has been proven to help by:

  • Easing the tooth extraction process
  • Assisting in gum disease treatment
  • Removing diseased areas of the teeth
  • Accessing the sinus cavity during a sinus lift

Dr. Sanchez routinely uses PIEZOSURGERY for the placement of dental implants, which are lifelike tooth replacement solutions that restore a patient’s bite and smile aesthetics. Dental implants are placed in areas of the mouth where teeth have been extracted or are missing and can even be used to replace an entire arch of missing teeth. Depending on a patient’s needs, Dr. Sanchez can provide new teeth in just one appointment.

PerioWest prides itself on offering patients comfortable treatments and gentle dentistry. By offering PIEZOSURGERY, Dr. Sanchez is able to give patients an improved experience. Additionally, the periodontist offers sedation options to help block discomfort and ease anxiety. Patients also benefit by choosing an experienced periodontist for their dental implant or tooth extraction needs. A periodontist, like Dr. Sanchez, has spent extra years studying the hard and soft tissues of the mouth, and can provide improved care during these major treatments.

Those interested in learning more about PIEZOSURGERY or dental implants, or who would like to schedule a private consultation with PerioWest’s periodontist in Eden Prairie, MN, are encouraged to visit the practice website at http://www.periowestmn.com or call 952-567-7457.

About the Periodontist

PerioWest is a periodontal practice offering personalized dental care for patients in Eden Prairie, MN and the Twin Cities areas. Dr. Andres R. Sanchez received his Certificate & Master’s Degree in Periodontics from the prestigious Mayo Clinic in Minnesota. He is a board-certified periodontist and a Diplomate of the American Board of Periodontology. In addition, Dr. Sanchez has been involved as a primary author in more than ten scientific papers published in major periodontal and implant dentistry journals. PerioWest provides state-of-the-art dental implant treatment, LANAP® laser therapy, and advanced periodontal care to Eden Prairie, MN and the Twin Cities areas. To learn more about Dr. Sanchez and the services provided at PerioWest, please visit the practice website at http://www.periowestmn.com or call 952-567-7457.

Share article on social media or email:

Thomas J. Giordano, Jr. invited to join Philadelphia Business Journal Leadership Trust


Headshot of Thomas J. Girodano, Esq., Pond Lehocky founding partner

Thomas J. Girodano, Esq., Pond Lehocky founding partner

Thomas J. Giordano, Jr, Esq., founding partner of Pond Lehocky and Pond Lehocky Disability, has been invited to join Philadelphia Business Journal Leadership Trust, an exclusive community for influential business leaders, executives, and entrepreneurs in Greater Philadelphia.

Tom was chosen for membership by the Philadelphia Business Journal Leadership Trust Selection Committee due to his experience, leadership, and influence in the local business landscape and beyond. Tom has dedicated his career to assisting disabled Americans. He leads Pond Lehocky Disability, the firm’s nationwide Social Security and disability insurance arm. The department has represented tens of thousands of disabled individuals in all 50 states. Giordano has also previously served on the board of directors of the Epilepsy Foundation of Eastern Pennsylvania. A graduate of Rutgers University School of Law – Camden, Giordano currently serves as the chair of the Social Security Disability Committee of the American Association for Justice and as the co-chair of the Social Security Disability section of the Philadelphia Bar Association.

“Philadelphia’s thriving business community is powered by leaders like Tom,” said Sandy Smith, market president and publisher of the Philadelphia Business Journal. “We’re honored to be creating a space where the regions business influencers come together to increase their impact on the community, build their businesses and connect with and strengthen one another.”

As an invited member, Tom will contribute articles to the Philadelphia Business Journal website and participate alongside fellow members in Expert Panels. He will connect and collaborate with a vetted network of local leaders in a members-only directory and a private forum on the group’s mobile app.

Tom will also benefit from leadership and business coaching, an Executive Profile on the Philadelphia Business Journal website, select partner discounts and services and ongoing support from the community’s concierge team.

The Philadelphia Business Journal Leadership Trust team is honored to welcome Tom the community and looks forward to helping him elevate his personal brand, strengthen his circle of trusted advisors and position him to further impact the Philadelphia business community and beyond.

About Business Journals Leadership Trust

Philadelphia Business Journal’s Leadership Trust is a part of Business Journals Leadership Trust is a collective of invitation-only networks of influential business leaders, executives and entrepreneurs in your community. Membership is based on an application and selection committee review. Benefits include private online forums, the ability to publish insights on bizjournals.com, business and executive coaching and a dedicated concierge team. To learn more and find out if you qualify, visit trust.bizjournals.com.

About Pond Lehocky

Pond Lehocky opened its doors in July 2010 with six attorneys and only 22 total staff members. Today, it is one of the largest workers’ compensation and Social Security disability law firms in Pennsylvania, helping workers with employment legal needs. The firm also has a robust referral network, helping Americans nationwide with all legal matters. Pond Lehocky has been honored with more than 60 awards over the past decade, being named Best Places to Work by The Philadelphia Business Journal six times and Top Workplaces by The Philadelphia Inquirer.

Share article on social media or email:

ICAA task force to lead senior living transformation after COVID-19


CEO of the International Council on Active Aging, an association that leads, connects and defines the active-aging industry, supports organizations and professionals that develop wellness environments and services for adults over 50.

Colin Milner, CEO of the International Council on Active Aging

The health, wellness and quality of life of our residents and staff are paramount as we chart a path forward in the midst of uncertainty.

A coalition of prominent industry associations representing all segments of senior living have joined more than 160 industry thought leaders and suppliers to provide guidance for communities throughout North America as they prepare to reopen safely after COVID-19.

Participants in the ICAA COVID-19 Senior Living Task Force include representatives of for-profit, not-for-profit, and affordable housing — organizations providing active-adult and independent living, continuing care retirement communities/life plan, assisted living, long-term care, skilled nursing, and rehabilitation

Participating industry associations include, among others, LeadingAge, American Senior Housing Association (ASHA), Argentum, American Medical Directors Association (AMDA), Pioneer Network, National Association of Area Agencies on Aging (N4A), National Council on Aging (NCOA), The National Association Directors of Nursing Administration in Long-Term Care (NADONA), and the American Society on Aging (ASA).

“The health, wellness and quality of life of our residents and staff are paramount as we chart a path forward in the midst of uncertainty,” said ICAA founder and CEO Colin Milner, who conceived the initiative. “The task force will develop, in conjunction with recommendations from the US Centers for Disease Control and Prevention (CDC), guidance for all senior living organizations as they plan when and how they will reopen their internal services, including wellness, therapy, spas, and cafes, to current and potential residents, as well as family members, staff and volunteers.”

Milner will co-chair the task force with Richard H. Carmona, MD, MPH, FACS, 17th US Surgeon General, Chief of Health Innovations, Canyon Ranch, and psychologist/gerontologist Ken Dychtwald, PhD, best-selling author, founder and CEO of Age Wave.

“Organizations need to make their way through the pandemic and have a game plan to come out of it,” Milner said. “Importantly, all key stakeholders are coming together as a group to address COVID-19’s impact on the industry, and help ensure that organizations will continue to be viable and meet residents’ expectations and desires while also ensuring their safety now and into the future.”

Task force members and panelists at the May 27 and May 28 launch sessions will address fundamental issues such as social distancing and its impact on the built environment, infrastructure needs and engagement.

Industry partners supporting the Task Forces efforts include: Humana, Matrix Fitness, CDW, NuStep, Keiser, Domtar, Merrithew, Delos, and iN2L.

About the ICAA COVID-19 Senior Living Industry Task Force

The ICAA COVID-19 Senior Living Task Force will, in conjunction with CDC recommendations, generate and provide ideas, tactics, strategies and messaging suggestions that organizations can consider, now and in the future, when planning to reopen their internal services (wellness, therapy, spas, cafes) and their communities to the outside population (family members, volunteers). This includes, but is not limited to, the impact of the built and virtual environments, social activities and food/beverage services, technology, education and security that impacts the health and well-being of staff and residents; challenges to current and future business models; and approaches to build confidence in living in and visiting senior living properties.

About the International Council on Active Aging (ICAA)

http://www.icaa.cc

ICAA is a professional association that leads, connects and defines the active-aging industry and supports professionals who aspire to develop wellness cultures for adults over 50. This support includes creating wellness environments, programs and services. The association is focused on active aging-an approach to aging that helps older adults live life as fully as possible within all dimensions of wellness-and provides its members with education, information, resources and tools. As an active-aging educator and advocate, ICAA has advised numerous organizations and governmental bodies.

Share article on social media or email:

180 Medical to Donate Thousands of Cases of Diapers to World Vision, CNY Diaper Bank, and the Englewood Health Foundation


News Image

In these times, many families are already worried about plenty of matters. We want to help take away the stress of worrying about diaper shortages in low-income homes with our donation, and we’re honored to be able to provide these extra supplies to families in need.

In response to the current shortage of diapers, wipes, and other essential household needs for children, low-income families, and individuals with special needs, 180 Medical is proud to announce the donation of thousands of cases of diapers to World Vision, CNY Diaper Bank, and the Englewood Health Foundation.

As a top supplier of catheters, ostomy products, and incontinence supplies, 180 Medical knows firsthand how important having access to medical supplies is for those in need. 180 Medical is dedicated to its mission of providing top-quality supplies while staying true to values of integrity and compassion. When the company saw the plight to those struggling to find supplies, it became clear that they needed to act.

John Holtz, COO of 180 Medical, states, “In these times, many families are already worried about plenty of matters. We want to help take away the stress of worrying about diaper shortages in low-income homes with our donation, and we’re honored to be able to provide these extra supplies to families in need in our local communities and all across America. As a company dedicated to making a difference, we truly hope our donation helps children and those living with specials needs to stay clean, dry, and healthy at home.”

180 Medical remains fully dedicated to providing the best in medical supplies along with compassionate customer service while operating with the highest standards of integrity.

Company/Organization Info:

180 Medical is one of America’s fastest-growing providers of sterile-use intermittent catheters, ostomy supplies, incontinence products, and other related disposable medical supplies. Headquartered in Oklahoma City, the company is committed to meeting the supply needs of customers with chronic medical diagnoses such as urinary incontinence, spinal cord injuries, spina bifida, colon cancer, Crohn’s disease, and many other conditions. 180 Medical is a subsidiary of ConvaTec, a leading global medical products and technologies company. To learn more, visit http://www.180medical.com.

Share article on social media or email:

Poms & Associates Rebrands with a New Logo, Website and Advertising Campaign, Launches Four New Risk/Cost Reduction Programs


Poms & Assoc. Logo

“Our company was founded on the belief that knowledge is the best insurance. Our new advertising campaign – along with our all-new website and four new product offerings – illustrate that principle.” – David Poms, founder and CEO of Poms & Associates.

Poms & Associates, an independent, full-service insurance brokerage and risk management firm, today revealed its new brand with a new logo and website and announced the launch of a new advertising campaign and a suite of four new and innovative risk and cost reduction programs for its clients.

“Our new visual identity is an expression of the decades of expertise and experience at Poms & Associates in helping businesses and organizations reduce their risk, loss and cost,” said David Poms, founder and CEO of Poms & Associates. “Our company was founded on the belief that knowledge is the best insurance. Our new advertising campaign – along with our all-new website and four new product offerings – illustrate that principle. Together, they highlight the many ways we’re responding to the changing needs of our clients with creative solutions to help them limit exposures and increase opportunities.”

The new branding campaign, titled “Smarter Insurance for Smarter Business,” presents direct, no-nonsense information about risk control and insurance and targets C-suite executives with an eye on the bottom line and a focus on the success of their company. A series of 30-second TV ads produced by Los Angeles advertising agency Glyphix will air over the next 12 months in the greater Los Angeles and Albuquerque, N.M. areas, two key markets in which Poms & Associates maintains branch offices. The first spot, titled “Relax,” began airing in April 2020. The second spot will air in May 2020. The ad campaign is supported with direct mail and print ads in local business publications.

In an addition to an all-new website, Poms & Associates has also launched four new proprietary programs that are focused on reducing both risk and cost. They include:


  • Poms QuarterbackTM – A guarantee to clients that they will get exactly the service and coverage they were promised; if they don’t see results, Poms & Associates will refund 25% of their fees.
  • Poms LookbackTM – A comprehensive review of past claims: risk management experts at Poms & Associates create a plan for clients that lowers open claim reserves and finds missed opportunities on closed claims with the aim of reducing future costs.
  • Poms BackstoryTM – A comprehensive review of employee categorization: experts at Poms & Associates review each client’s employee to ensure proper categorization thus reducing risk profile and premium costs.
  • Poms FallbackTM – A program focused on preventing injuries: risk management experts at Poms & Associates work will clients to identify and implement solutions that reduce claims, lower the amount of claims filed and improve working conditions.

“At Poms & Associates, we have no greater focus than delivering the highest level of customer service to our clients – and the communities in which they operate – as a means to improving and protecting people’s lives,” said Poms. “Our four new programs are all innovatively designed to reduce risk and cost as much as possible for clients. We’re excited to offer these programs that resulted from our out-of-the-box thinking about ways to achieve greater returns on investment for clients.”

For more information about Poms & Associates, visit https://pomsassoc.com/.

About Poms & Associates

Poms & Associates is a leading independent, full-service insurance brokerage and risk management firm with a proven track record of providing innovative and customized solutions to businesses in high-risk industries. Founded in 1991, the company was built on the premise that knowledge is the best insurance – that is, the best way to help businesses and organizations is to serve not only as an insurance broker but also as an educator about best practices in how to reduce risk and prevent loss before an incident occurs. Poms & Associates today offers a wide range of products and services, including property and casualty insurance for commercial organizations and public entities, risk control, human resources and employee benefits and private services for high net-worth individuals. Among the top 50 independent brokerage firms in the U.S., Poms & Associates is headquartered in Woodland Hills, Calf. It maintains branch offices in Los Angeles, Sacramento, Calif., the San Francisco Bay Area, Albuquerque, N.M. and Dayton, Ohio. For more information, visit https://pomsassoc.com/.

Share article on social media or email:

Terry Gallaher joins Inte Q, Leading CRM and Loyalty Agency, as Chief Customer Officer


Terry Gallaher, Chief Client Officer, Inte Q

Terry Gallaher, Chief Client Officer, Inte Q

“Adding talented people like Terry to our already very talented team, is a big win for Inte Q. Terry’s thought leadership and client-centric mindset will create a strong vision for how we work with our clients, and help us achieve our aggressive growth plans,” said Chris Duncan, Inte Q President.

Inte Q, a leader in building effective customer loyalty strategies, campaigns and experiences for brands, is excited to announce Terry Gallaher has joined the organization as Chief Customer Officer. In his role Terry will lead all client functions, including strategic sales, account management and client services. With more than twenty years of sales executive and management experience, Terry has successfully built relationships, collaborated and delivered strategic solutions to Fortune 500 brands in retail, financial and digital media verticals.

Terry brings experience from some of the world’s most well-known brands and brings a long track record of successfully helping clients grow their business. Previously, Terry held senior roles with Salesforce and Google where he worked with marquee retail brands including Target, Kohl’s, Best Buy, and Walgreens. During his tenure at Google, Terry was awarded the 2018 “Retail Visionary Award” by Big Box Retail and the “Trailblazer Gold Sales Award,” in which he was honored as one of fifty sales leaders in America’s Largest Customer Sales Organization.

“I am thrilled to have Terry join Inte Q. Adding talented people like Terry to our already very talented team, is a big win for Inte Q. Terry’s thought leadership and client-centric mindset will create a strong vision for how we work with our clients, and help us achieve our aggressive growth plans,” said Chris Duncan, Inte Q President.

“I am excited to join such an innovative company like Inte Q and I look forward to bring the experience that I’ve gained at world-class companies like Salesforce and Google to add to the success that Inte Q has experienced,” said Terry Gallaher.

Terry will be located at Inte Q’s headquarter in Oakbrook Terrace, Illinois.

About Inte Q

Inte Q is an insights and activation agency that develops data-driven strategies to help brands create Customer Love® – turning casual shoppers into brand loyalists. With a deep understanding of customer engagement, the company builds effective customer engagement strategies, campaigns and experiences for its clients.

Share article on social media or email: